Table 1. The relationship between IER3 expression and clinicopathological arguments of HCC based on in-house IHC.
| Clinicopathologic arguments | Number | IER3 expression | R | p-value | |
|---|---|---|---|---|---|
| Tissue | HCC | 94 | 10.64 ± 2.08 | 0.725 | <0.001 |
| Non-HCC | 127 | 6.50 ± 2.73 | |||
| Age | <60 | 171 | 8.03 ± 3.24 | 0.843 | <0.001 |
| ≥60 | 50 | 9.04 ± 3.00 | |||
| Gender | Female | 64 | 7.61 ± 3.67 | –0.053 | 0.677 |
| Male | 157 | 8.52 ± 2.97 | |||
| Pathologic grade | I–II | 63 | 10.73 ± 1.88 | –0.164 | 0.353 |
| III–IV | 24 | 10.67 ± 2.55 | |||
| Alcohol history | No | 54 | 9.37 ± 3.10 | 0.211 | 0.128 |
| Yes | 53 | 10.64 ± 2.21 | |||
| Alpha-fetoprotein (AFP) | <20 ng/mL | 44 | 8.86 ± 3.30 | –0.076 | 0.021 |
| >20 ng/mL | 62 | 10.77 ± 2.12 | |||
Notes.
- HCC
- hepatocellular carcinoma
- IER3
- immediate early response 3
- IHC
- immunohistochemistry
- R
- Pearson correlation coefficient